This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Biopharmaceutical Proteins. Top assignee: Novagen Holding Corporation. Active years: 2009-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2022
Areas of Expertise:
Title: Haitao Wang: Innovator in Recombinant Fusion Proteins
Introduction
Haitao Wang is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the field of biotechnology. He holds a total of 16 patents, showcasing his innovative approach to developing advanced therapeutic solutions.
Latest Patents
Wang's latest patents include groundbreaking work on recombinant human EPO-FC fusion proteins. This invention describes a recombinant fusion protein that comprises a human erythropoietin peptide portion linked to an immunoglobulin peptide portion. The fusion protein boasts a prolonged half-life in vivo compared to naturally occurring or recombinant native human erythropoietin. In one embodiment, the protein exhibits a half-life at least threefold higher than that of native human erythropoietin, along with enhanced erythropoietic bioactivity. The invention also encompasses nucleic acid and amino acid sequences encoding the fusion protein, as well as methods for producing it and pharmaceutical compositions that utilize the fusion protein for therapeutic purposes.
Another notable patent involves fusion proteins with mutated immunoglobulin hinge regions. This innovation features a fusion protein that includes a non-immunoglobulin polypeptide with a cysteine residue and an immunoglobulin component with a mutated hinge region. The design prevents the formation of disulfide bonds, enhancing the protein's functionality.
Career Highlights
Haitao Wang is currently associated with Novagen Holding Corporation, where he continues to push the boundaries of biopharmaceutical research. His work has significantly impacted the development of therapies aimed at stimulating erythropoiesis in patients requiring treatment.
Collaborations
Wang collaborates with esteemed colleagues such as Rui Zhang and Jing Xu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Haitao Wang's contributions to the field of biotechnology, particularly in the development of recombinant fusion proteins, highlight his role as a leading inventor. His work not only advances scientific knowledge but also holds the potential for significant therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile